Remove Article Remove Concentrates Remove Data Remove Information
article thumbnail

Article: Class Actions Increasingly Targeting Cannabis Companies

Cannabis Law Report

CBE have published the following article. Read the full article at. From data-related class action concerns to security disclosures and labeling issues, cannabis companies may see themselves facing class action filings. Here are a selection of the highlights. Increasing Cannabis Class Action Risks.

CBD 85
article thumbnail

FDA Publish Article “5 Things to Know about Delta-8 Tetrahydrocannabinol – Delta-8 THC”

Cannabis Law Report

As a result, concentrated amounts of delta-8 THC are typically manufactured from hemp-derived cannabidiol (CBD). . Some concerns include variability in product formulations and product labeling, other cannabinoid and terpene content, and variable delta-8 THC concentrations. synthetic conversion).

THC 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

WTR Article: Brand building in the cannabis industry

Cannabis Law Report

Drilling down into the cannabis trademark landscape in 2018 uncovered a heavy focus on goods in Classes 34 (smokers’ articles) and 5 (medicines/pharmaceuticals), as well as Nice classes relating to food and drink products. Smokers’ articles. Smokers’ articles. Agricultural products. Retail services. Medical services.

Oil 71
article thumbnail

Here’s what you need to know about cannabis research

The Cannigma

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.

article thumbnail

CRN Denounces FDA Rejection of New Dietary Ingredient Notifications for Hemp Extract Containing CBD, Urges Congress to Act

Cannabis Law Report

FDA has wrongly mischaracterized these products as the same article as a prescription drug and has ignored, dismissed, and downplayed ample evidence that these full-spectrum hemp products can be marketed in a manner that is reasonably expected to be safe. In June 2019, CRN submitted comments to FDA with scientific data and information on CBD.

article thumbnail

Article: Track and Trace for Medical and Adult Use Marijuana Programs

Cannabis Law Report

The Chief Operating Officer of BioTrackTHC, Moe Afaneh, gave a high-level overview of the company’s seed-to-sale software for state-level data collection. Any individual who will be inputting data into the track and trace system under either the medical or adult use program must be registered with OMP and will need to receive training.

article thumbnail

Next Steps for Operators Interested in the Fastest-Growing Concentrates Category

SpeedWeed

With this data in hand, Novel said Ultra Health can take an active role in the rulemaking process by providing informed feedback on the proposed regulations to hopefully help guide what the application and, ultimately, the industry will look like. ” View original article.